After stopping lisinopril, how long should I wait before initiating losartan, particularly if the lisinopril was discontinued due to severe ACE‑inhibitor‑induced angioedema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Lisinopril to Losartan: Timing and Safety Considerations

Direct Answer for Routine Switching

In routine clinical scenarios without angioedema, you can start losartan immediately after stopping lisinopril—no waiting period is required. 1

  • A randomized controlled trial specifically evaluated immediate switching from captopril (an ACE inhibitor) to losartan in 177 hypertensive patients and found no clinically significant hypotension or adverse events requiring a washout period 1
  • Within 12 hours of switching, only 3% of patients on losartan had systolic BP readings below 100 mmHg, which was not statistically different from those who continued ACE inhibitor therapy 1
  • The study concluded that losartan was "effective and generally well tolerated when administered immediately after pretreatment with an ACE inhibitor" 1

Critical Exception: ACE Inhibitor-Induced Angioedema

If lisinopril was discontinued due to angioedema, you should NOT prescribe losartan or any other ARB—this is an absolute contraindication. 2, 3

Why ARBs Are Contraindicated After ACE Inhibitor Angioedema

  • The American Heart Association explicitly states that another ARB should never be used if the patient had an allergic reaction (including angioedema) to an ACE inhibitor due to cross-reactivity risk 3
  • The European Society of Cardiology advises against using ARBs in patients with a history of angioedema with ACE inhibitors 2
  • Despite initial theories that ARBs would not cause angioedema (since they don't affect bradykinin metabolism), multiple case reports demonstrate that losartan can indeed cause angioedema 4, 5, 6
  • Angioedema with losartan has been documented in patients with prior ACE inhibitor-induced angioedema, confirming cross-reactivity 5
  • The reaction can occur anywhere from 24 hours to 16 months after starting losartan, and can recur even after initial resolution 4, 5

Alternative Medications After ACE Inhibitor Angioedema

If you need renin-angiotensin system blockade after ACE inhibitor angioedema, wait a minimum of 6 weeks, then consider cautiously reintroducing an ACE inhibitor—NOT an ARB. 3

  • The American College of Cardiology and American Heart Association recommend a 6-week waiting period before considering ACE inhibitor rechallenge due to documented cross-reactivity patterns 3
  • This counterintuitive recommendation reflects that ACE inhibitor angioedema may be idiosyncratic rather than purely bradykinin-mediated 6

For immediate blood pressure control without waiting, use calcium channel blockers or thiazide diuretics instead: 3

  • Calcium channel blockers: Amlodipine 2.5-10 mg once daily is recommended by the American College of Cardiology for immediate BP control 3
  • Thiazide diuretics: Chlorthalidone 12.5-25 mg once daily is an alternative, particularly for elderly patients or isolated systolic hypertension 3

Practical Initiation Protocol for Routine Switching (No Angioedema History)

When switching from lisinopril to losartan in standard clinical scenarios:

  1. Day 1: Stop lisinopril, start losartan 50 mg once daily (or 25 mg if elderly/volume depleted) 7, 8
  2. Week 1: Check renal function and potassium 7, 8
  3. Weeks 2-4: Titrate to target dose of 100 mg daily if tolerated 8
  4. Week 4: Recheck creatinine and potassium after dose increase 7, 8

Monitoring Parameters

  • An initial creatinine rise of 10-20% is expected and acceptable, representing hemodynamic changes rather than kidney injury 2
  • Progressive increases beyond 30% from baseline warrant discontinuation 2
  • Monitor potassium closely, especially in patients with CKD or on potassium supplements 3, 8

Common Pitfalls to Avoid

Never combine losartan with an ACE inhibitor or direct renin inhibitor: 2, 8

  • The American Heart Association explicitly advises against this combination due to increased risk of hyperkalemia, hypotension, and renal dysfunction 2
  • The VALIANT trial showed that combining valsartan with captopril increased adverse events without improving survival 7

Do not use losartan in patients with bilateral renal artery stenosis: 2

  • Angiotensin II is necessary for maintaining GFR when renal perfusion is compromised 2

Avoid in severe volume depletion states: 2

  • Hold during severe dehydration, aggressive diuresis, or symptomatic hypotension 2

References

Guideline

When to Hold Irbesartan Due to Renal or Cardiovascular Risks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hypertension After Allergic Reaction to Losartan

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Losartan-induced angioedema.

The Annals of pharmacotherapy, 1999

Research

Angioneurotic edema attributed to the use of losartan.

Archives of internal medicine, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Losartan Dosing in Patients with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.